17:18 , Aug 8, 2019 |  BC Innovations  |  Distillery Therapeutics

RNF2 inhibition to treat prostate cancer

DISEASE CATEGORY: Cancer INDICATION: Prostate cancer Inhibiting the RNF2 subunit of PRC1 could treat double-negative prostate cancer (DNPC), a subtype of metastatic prostate cancer characterized by a non-responsive androgen receptor pathway and lacking neuroendocrine traits....
02:24 , Mar 29, 2019 |  BC Innovations  |  Targets & Mechanisms

Next-wave targets at AACR 2019 start filling the blanks in the tumor microenvironment

New and emerging targets at AACR 2019 show cancer researchers are gaining granularity on how to manipulate the tumor microenvironment, a top priority goal for the field. The targets point to emerging strategies for modulating...